Universal Starch Chem Allied Share Price
Sector: Crops
168.70 +4.60 (2.80%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
161.00
Today’s High
170.00
52 Week Low
141.25
52 Week High
282.00
Key Metrics
- Market Cap (In Cr) 70.96
- Beta 0.11
- Div. Yield (%) 0
- P/B 0.98
- TTM P/E 20.35
- Sector P/E 20.84
- D/E 0.01
- Open Price 170
- Prev Close 164.1
Universal Starch Chem Allied Analysis
Price Analysis
-
1 Week-0.88%
-
3 Months4.66%
-
6 Month-2.66%
-
YTD-6.91%
-
1 Year-13.07%
Risk Meter
- 58% Low risk
- 58% Moderate risk
- 58% Balanced Risk
- 58% High risk
- 58% Extreme risk
Universal Starch Chem Allied News
Q4 results today: GIC, Aurobindo Pharma, Sumitomo Chemical, Nazara Tech, more
1 min read . 26 May 2025Universal Starch Chem Allied Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 490.89
- Selling/ General/ Admin Expenses Total
- 19.37
- Depreciation/ Amortization
- 6.28
- Other Operating Expenses Total
- 49.65
- Total Operating Expense
- 478.82
- Operating Income
- 12.08
- Net Income Before Taxes
- 4.27
- Net Income
- 3.21
- Diluted Normalized EPS
- 7.65
- Period
- 2025
- Total Assets
- 225.51
- Total Liabilities
- 155.72
- Total Equity
- 69.8
- Tangible Book Valueper Share Common Eq
- 166.15
- Period
- 2025
- Cashfrom Operating Activities
- 22.58
- Cashfrom Investing Activities
- -18.48
- Cashfrom Financing Activities
- -4.55
- Net Changein Cash
- -0.45
- Period
- 2024
- Total Revenue
- 527.13
- Selling/ General/ Admin Expenses Total
- 19.09
- Depreciation/ Amortization
- 5.79
- Other Operating Expenses Total
- 54.46
- Total Operating Expense
- 512.8
- Operating Income
- 14.33
- Net Income Before Taxes
- 9.22
- Net Income
- 6.99
- Diluted Normalized EPS
- 16.63
- Period
- 2024
- Total Assets
- 223.97
- Total Liabilities
- 157.4
- Total Equity
- 66.57
- Tangible Book Valueper Share Common Eq
- 158.46
- Period
- 2024
- Cashfrom Operating Activities
- 19.01
- Cashfrom Investing Activities
- -9.11
- Cashfrom Financing Activities
- -10.4
- Net Changein Cash
- -0.5
- Period
- 2023
- Total Revenue
- 515.76
- Selling/ General/ Admin Expenses Total
- 16.16
- Depreciation/ Amortization
- 5.09
- Other Operating Expenses Total
- 58.43
- Total Operating Expense
- 503.52
- Operating Income
- 12.24
- Net Income Before Taxes
- 8.1
- Net Income
- 5.9
- Diluted Normalized EPS
- 14.05
- Period
- 2023
- Total Assets
- 204.34
- Total Liabilities
- 146.1
- Total Equity
- 58.25
- Tangible Book Valueper Share Common Eq
- 138.65
- Period
- 2023
- Cashfrom Operating Activities
- -0.87
- Cashfrom Investing Activities
- -8.95
- Cashfrom Financing Activities
- 13.79
- Net Changein Cash
- 3.97
- Period
- 2022
- Total Revenue
- 456.13
- Selling/ General/ Admin Expenses Total
- 15.03
- Depreciation/ Amortization
- 4.32
- Other Operating Expenses Total
- 57.97
- Total Operating Expense
- 434.9
- Operating Income
- 21.24
- Net Income Before Taxes
- 15.8
- Net Income
- 11.44
- Diluted Normalized EPS
- 27.23
- Period
- 2022
- Total Assets
- 187.04
- Total Liabilities
- 134.75
- Total Equity
- 52.29
- Tangible Book Valueper Share Common Eq
- 124.46
- Period
- 2022
- Cashfrom Operating Activities
- 34.42
- Cashfrom Investing Activities
- -18.29
- Cashfrom Financing Activities
- -18.42
- Net Changein Cash
- -2.29
- Period
- 2021
- Total Revenue
- 296.37
- Selling/ General/ Admin Expenses Total
- 13.3
- Depreciation/ Amortization
- 4
- Other Operating Expenses Total
- 38.21
- Total Operating Expense
- 282.86
- Operating Income
- 13.51
- Net Income Before Taxes
- 7.23
- Net Income
- 6.36
- Diluted Normalized EPS
- 15.14
- Period
- 2021
- Total Assets
- 175.34
- Total Liabilities
- 134.41
- Total Equity
- 40.94
- Tangible Book Valueper Share Common Eq
- 97.43
- Period
- 2021
- Cashfrom Operating Activities
- 10.7
- Cashfrom Investing Activities
- -9.01
- Cashfrom Financing Activities
- 0.86
- Net Changein Cash
- 2.55
- Period
- 2020
- Total Revenue
- 263.8
- Selling/ General/ Admin Expenses Total
- 10.54
- Depreciation/ Amortization
- 4.93
- Other Operating Expenses Total
- 23.96
- Total Operating Expense
- 258.78
- Operating Income
- 5.02
- Net Income Before Taxes
- 0.41
- Net Income
- 0.66
- Diluted Normalized EPS
- 1.57
- Period
- 2020
- Total Assets
- 156.96
- Total Liabilities
- 118.96
- Total Equity
- 38
- Tangible Book Valueper Share Common Eq
- 90.44
- Period
- 2020
- Cashfrom Operating Activities
- 10.58
- Cashfrom Investing Activities
- -0.85
- Cashfrom Financing Activities
- -11.12
- Net Changein Cash
- -1.38
- Period
- 2019
- Total Revenue
- 278.95
- Selling/ General/ Admin Expenses Total
- 10.57
- Depreciation/ Amortization
- 4.42
- Other Operating Expenses Total
- 24.76
- Total Operating Expense
- 271.92
- Operating Income
- 7.03
- Net Income Before Taxes
- 3.08
- Net Income
- 1.42
- Diluted Normalized EPS
- 3.37
- Period
- 2019
- Total Assets
- 148.56
- Total Liabilities
- 112.11
- Total Equity
- 36.46
- Tangible Book Valueper Share Common Eq
- 86.76
- Period
- 2019
- Cashfrom Operating Activities
- 11.17
- Cashfrom Investing Activities
- -18.49
- Cashfrom Financing Activities
- 9.58
- Net Changein Cash
- 2.26
- Period
- 2025-03-31
- Total Revenue
- 138.14
- Selling/ General/ Admin Expenses Total
- 5.2
- Depreciation/ Amortization
- 1.7
- Other Operating Expenses Total
- 11.77
- Total Operating Expense
- 132.14
- Operating Income
- 5.99
- Net Income Before Taxes
- 3.91
- Net Income
- 2.94
- Diluted Normalized EPS
- 7.01
- Period
- 2025-03-31
- Total Assets
- 225.51
- Total Liabilities
- 155.72
- Total Equity
- 69.8
- Tangible Book Valueper Share Common Eq
- 166.15
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 22.58
- Cashfrom Investing Activities
- -18.48
- Cashfrom Financing Activities
- -4.55
- Net Changein Cash
- -0.45
- Period
- 2024-12-31
- Total Revenue
- 128.56
- Selling/ General/ Admin Expenses Total
- 4.9
- Depreciation/ Amortization
- 1.57
- Other Operating Expenses Total
- 12.6
- Total Operating Expense
- 119.64
- Operating Income
- 8.92
- Net Income Before Taxes
- 7.06
- Net Income
- 7.02
- Diluted Normalized EPS
- 16.72
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 90.93
- Selling/ General/ Admin Expenses Total
- 4.66
- Depreciation/ Amortization
- 1.53
- Other Operating Expenses Total
- 11.91
- Total Operating Expense
- 97.67
- Operating Income
- -6.74
- Net Income Before Taxes
- -8.71
- Net Income
- -8.22
- Diluted Normalized EPS
- -19.57
- Period
- 2024-09-30
- Total Assets
- 200.83
- Total Liabilities
- 141
- Total Equity
- 59.83
- Tangible Book Valueper Share Common Eq
- 142.42
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 20.33
- Cashfrom Investing Activities
- -14.84
- Cashfrom Financing Activities
- -5.24
- Net Changein Cash
- 0.25
- Period
- 2024-06-30
- Total Revenue
- 133.27
- Selling/ General/ Admin Expenses Total
- 4.61
- Depreciation/ Amortization
- 1.48
- Other Operating Expenses Total
- 13.38
- Total Operating Expense
- 129.36
- Operating Income
- 3.9
- Net Income Before Taxes
- 2
- Net Income
- 1.46
- Diluted Normalized EPS
- 3.49
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 145.05
- Selling/ General/ Admin Expenses Total
- 4.85
- Depreciation/ Amortization
- 1.47
- Other Operating Expenses Total
- 13.33
- Total Operating Expense
- 139.13
- Operating Income
- 5.93
- Net Income Before Taxes
- 5.76
- Net Income
- 2.92
- Diluted Normalized EPS
- 6.95
- Period
- 2024-03-31
- Total Assets
- 223.97
- Total Liabilities
- 157.4
- Total Equity
- 66.57
- Tangible Book Valueper Share Common Eq
- 158.46
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 19.01
- Cashfrom Investing Activities
- -9.11
- Cashfrom Financing Activities
- -10.4
- Net Changein Cash
- -0.5
- Period
- 2023-12-31
- Total Revenue
- 126.25
- Selling/ General/ Admin Expenses Total
- 4.82
- Depreciation/ Amortization
- 1.5
- Other Operating Expenses Total
- 14.06
- Total Operating Expense
- 125.8
- Operating Income
- 0.45
- Net Income Before Taxes
- -1.4
- Net Income
- -0.98
- Diluted Normalized EPS
- -2.34
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Universal Starch Chem Allied Technical
Moving Average
SMA
- 5 Day167.66
- 10 Day164.26
- 20 Day164.5
- 50 Day165.99
- 100 Day166.33
- 300 Day178.23
Universal Starch Chem Allied Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Raghuvansh Agrofarms
- 80
- 0
- 0
- 215
- 69
- 95.34
- Agri-tech India
- 157
- -1.2
- -0.76
- 307
- 122
- 93.26
- Universal Starch Chem Allied
- 168.7
- 4.6
- 2.8
- 282
- 141.25
- 70.96
- Nagarjuna Agri Tech
- 70.67
- -1.44
- -2
- 83.34
- 17.64
- 66.21
- Norben Tea And Exports
- 34.6
- -1
- -2.81
- 51.16
- 12
- 44.87
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Raghuvansh Agrofarms
- 15.15
- 1.27
- 9.54
- 37.82
- Agri-tech India
- -
- 0.93
- 1.61
- 743.73
- Universal Starch Chem Allied
- 21.29
- 0.98
- 12.47
- 1.48
- Nagarjuna Agri Tech
- 1205.77
- 9.82
- 7.68
- 16.95
- Norben Tea And Exports
- -
- 2.72
- -1.04
- -2.13
Universal Starch Chem Allied Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 26-May-25
- Audited Results
- 10-Feb-25
- Quarterly Results
- 09-Nov-24
- Quarterly Results
- 10-Aug-24
- Quarterly Results
- 28-May-24
- Audited Results
- 10-Feb-24
- Quarterly Results
- 10-Nov-23
- Quarterly Results
- 12-Aug-23
- Quarterly Results
- 27-May-23
- Audited Results
- 13-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 28-Feb-25
- 28-Jan-25
- POM
- 30-Sept-24
- 12-Aug-24
- AGM
- 30-Sept-23
- 16-Aug-23
- AGM



